Overview
Maarten Naesens practices in Leuven, Belgium. Mr. Naesens is rated as an Experienced expert by MediFind in the treatment of Glomerulonephritis. His top areas of expertise are Chronic Kidney Disease, Focal Segmental Glomerulosclerosis, Glomerulonephritis, Kidney Transplant, and Heart Transplant.
His clinical research consists of co-authoring 279 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Glomerulonephritis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Kidney TransplantMr. Naesens isElite. Learn about Kidney Transplant.
- Advanced
- Chronic Kidney DiseaseMr. Naesens isAdvanced. Learn about Chronic Kidney Disease.
- Heart TransplantMr. Naesens isAdvanced. Learn about Heart Transplant.
- Experienced
- Bronchiolitis ObliteransMr. Naesens isExperienced. Learn about Bronchiolitis Obliterans.
- Cerebral HypoxiaMr. Naesens isExperienced. Learn about Cerebral Hypoxia.
- Cytomegalic Inclusion DiseaseMr. Naesens isExperienced. Learn about Cytomegalic Inclusion Disease.
- Cytomegalovirus InfectionMr. Naesens isExperienced. Learn about Cytomegalovirus Infection.
- Diabetic NephropathyMr. Naesens isExperienced. Learn about Diabetic Nephropathy.
- End-Stage Renal Disease (ESRD)Mr. Naesens isExperienced. Learn about End-Stage Renal Disease (ESRD).